{"id":13885,"date":"2026-02-24T18:52:36","date_gmt":"2026-02-24T17:52:36","guid":{"rendered":"https:\/\/wise3.sk\/?p=13885"},"modified":"2026-02-24T18:55:36","modified_gmt":"2026-02-24T17:55:36","slug":"a-cartel-in-drug-supply-how-a-whistleblower-changed-the-game","status":"publish","type":"post","link":"https:\/\/wise3.sk\/en\/hospodarska-sutaz-a-statna-pomoc\/a-cartel-in-drug-supply-how-a-whistleblower-changed-the-game\/","title":{"rendered":"A Cartel in Drug Supply: How a Whistleblower Changed the Game"},"content":{"rendered":"\n
\n
\n
\n
\n \n
\n
\n

Earlier this year, Slovakia’s Antimonopoly Office (AMO) announced one of its most significant competition law decisions to date \u2014 uncovering a cartel in the supply of pharmaceuticals for public procurement and imposing fines totalling nearly \u20ac7.8 million. But what makes this case truly landmark is how<\/em> it was cracked open: for the first time in Slovak history, a whistleblower played a decisive role in exposing the illegal scheme.<\/p>

What happened?<\/strong><\/p>

The cartel involved the supply and distribution of categorised medicines for V\u0161eobecn\u00e1 zdravotn\u00e1 pois\u0165ov\u0148a (the General Health Insurance Company) and spanned from December 2017 to September 2020. During this period, competitors coordinated their behaviour \u2014 rather than competing fairly in public tenders \u2014 in one of the most serious forms of competition law infringement possible.<\/p>

The AMO sanctioned two companies. PHOENIX Zdravotn\u00edcke z\u00e1sobovanie received a fine of \u20ac7,595,200 and a one-year ban from public procurement. TRANSMEDIC SLOVAKIA (in bankruptcy proceedings) was fined \u20ac201,800 and banned from tenders for three years. PHOENIX’s fine was reduced as the company admitted its involvement and agreed to a settlement with the authority \u2014 a mechanism that allows for lower sanctions in exchange for cooperation and acceptance of responsibility.<\/p>

The whistleblower factor<\/strong><\/p>

This is where the case becomes particularly important. The information provided by an individual whistleblower enabled the AMO to carry out an inspection and gather the necessary evidence \u2014 something that might never have happened otherwise. Slovak law incentivises this kind of reporting: the first person to provide decisive evidence is entitled to a reward of 1% of the fines imposed, up to a maximum of \u20ac100,000.<\/p>

Previously, Slovak cartel cases were typically uncovered either through the AMO’s own investigations or through the leniency programme, where one of the participating companies chose to cooperate. This case marks a meaningful shift \u2014 an individual from within the industry came forward, and it made all the difference.<\/p>

Why this matters for businesses<\/strong><\/p>

The message from this case is clear and worth sitting with: the risk of cartel exposure is no longer limited to external regulatory scrutiny. It now comes from within organisations themselves.<\/p>

Whistleblower protection frameworks and financial incentives are beginning to have real, practical consequences in the Slovak market. For companies operating in regulated industries \u2014 and frankly, any industry involved in public procurement \u2014 this should prompt a serious look at internal compliance culture. Transparency and fair competition are no longer just reputational advantages. They are becoming a business necessity.<\/p>

The AMO’s decision signals that cartels are being actively monitored, and that whistleblowing is emerging as a genuine and effective market oversight tool. The question for businesses is no longer just „will regulators find out?“<\/em> \u2014 it’s „will someone on the inside speak up?“<\/em><\/p>

\u00a0<\/p>

Photo source: Protimonopoln\u00fd \u00farad Slovenskej republiky\u00a0<\/p>

\nhttps:\/\/www.antimon.gov.sk\/kartely-pmu-aj-vdaka-whistleblowerovi-odhalil-kartel-v-dodavkach-liekov-a-ulozil-pokuty-takmer-78-miliona-eur\/\n<\/p> <\/div>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n","protected":false},"excerpt":{"rendered":"

Earlier this year, Slovakia’s Antimonopoly Office (AMO) announced one of its most significant competition law decisions to date \u2014 uncovering a cartel in the supply of pharmaceuticals for public procurement and imposing fines totalling nearly \u20ac7.8 million. But what makes this case truly landmark is how it was cracked open: for the first time in […]<\/p>\n","protected":false},"author":12,"featured_media":13888,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"16","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[1,16,21],"tags":[],"class_list":["post-13885","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advokati-na-vasej-strane","category-hospodarska-sutaz-a-statna-pomoc","category-regulacne-zalezitosti-compliance","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"builder_content":"

Earlier this year, Slovakia's Antimonopoly Office (AMO) announced one of its most significant competition law decisions to date \u2014 uncovering a cartel in the supply of pharmaceuticals for public procurement and imposing fines totalling nearly \u20ac7.8 million. But what makes this case truly landmark is how<\/em> it was cracked open: for the first time in Slovak history, a whistleblower played a decisive role in exposing the illegal scheme.<\/p>

What happened?<\/strong><\/p>

The cartel involved the supply and distribution of categorised medicines for V\u0161eobecn\u00e1 zdravotn\u00e1 pois\u0165ov\u0148a (the General Health Insurance Company) and spanned from December 2017 to September 2020. During this period, competitors coordinated their behaviour \u2014 rather than competing fairly in public tenders \u2014 in one of the most serious forms of competition law infringement possible.<\/p>

The AMO sanctioned two companies. PHOENIX Zdravotn\u00edcke z\u00e1sobovanie received a fine of \u20ac7,595,200 and a one-year ban from public procurement. TRANSMEDIC SLOVAKIA (in bankruptcy proceedings) was fined \u20ac201,800 and banned from tenders for three years. PHOENIX's fine was reduced as the company admitted its involvement and agreed to a settlement with the authority \u2014 a mechanism that allows for lower sanctions in exchange for cooperation and acceptance of responsibility.<\/p>

The whistleblower factor<\/strong><\/p>

This is where the case becomes particularly important. The information provided by an individual whistleblower enabled the AMO to carry out an inspection and gather the necessary evidence \u2014 something that might never have happened otherwise. Slovak law incentivises this kind of reporting: the first person to provide decisive evidence is entitled to a reward of 1% of the fines imposed, up to a maximum of \u20ac100,000.<\/p>

Previously, Slovak cartel cases were typically uncovered either through the AMO's own investigations or through the leniency programme, where one of the participating companies chose to cooperate. This case marks a meaningful shift \u2014 an individual from within the industry came forward, and it made all the difference.<\/p>

Why this matters for businesses<\/strong><\/p>

The message from this case is clear and worth sitting with: the risk of cartel exposure is no longer limited to external regulatory scrutiny. It now comes from within organisations themselves.<\/p>

Whistleblower protection frameworks and financial incentives are beginning to have real, practical consequences in the Slovak market. For companies operating in regulated industries \u2014 and frankly, any industry involved in public procurement \u2014 this should prompt a serious look at internal compliance culture. Transparency and fair competition are no longer just reputational advantages. They are becoming a business necessity.<\/p>

The AMO's decision signals that cartels are being actively monitored, and that whistleblowing is emerging as a genuine and effective market oversight tool. The question for businesses is no longer just \"will regulators find out?\"<\/em> \u2014 it's \"will someone on the inside speak up?\"<\/em><\/p>

\u00a0<\/p>

Photo source: Protimonopoln\u00fd \u00farad Slovenskej republiky\u00a0<\/p>

https:\/\/www.antimon.gov.sk\/kartely-pmu-aj-vdaka-whistleblowerovi-odhalil-kartel-v-dodavkach-liekov-a-ulozil-pokuty-takmer-78-miliona-eur\/<\/p>","_links":{"self":[{"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/posts\/13885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/comments?post=13885"}],"version-history":[{"count":4,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/posts\/13885\/revisions"}],"predecessor-version":[{"id":13892,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/posts\/13885\/revisions\/13892"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/media\/13888"}],"wp:attachment":[{"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/media?parent=13885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/categories?post=13885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wise3.sk\/en\/wp-json\/wp\/v2\/tags?post=13885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}